Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nrf2, but not β‐catenin, mutation represents an early event in rat hepatocarcinogenesis
Patrizia Zavattari, Andrea Perra, Silvia Menegon, et al.
Hepatology (2015) Vol. 62, Iss. 3, pp. 851-862
Closed Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Oxidative Stress in Cancer
John D. Hayes, Albena T. Dinkova‐Kostova, Kenneth D. Tew
Cancer Cell (2020) Vol. 38, Iss. 2, pp. 167-197
Open Access | Times Cited: 1839
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee, Helen L. Reeves, Elena Kotsiliti, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 7, pp. 411-428
Closed Access | Times Cited: 1147
The Dual Roles of NRF2 in Cancer
Silvia Menegon, Amedeo Columbano, Silvia Giordano
Trends in Molecular Medicine (2016) Vol. 22, Iss. 7, pp. 578-593
Open Access | Times Cited: 566
p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells
Atsushi Umemura, Feng He, Koji Taniguchi, et al.
Cancer Cell (2016) Vol. 29, Iss. 6, pp. 935-948
Open Access | Times Cited: 413
Genotype‐phenotype correlation of CTNNB1 mutations reveals different ß‐catenin activity associated with liver tumor progression
Sandra Rebouissou, Andrea Franconi, Julien Caldéraro, et al.
Hepatology (2016) Vol. 64, Iss. 6, pp. 2047-2061
Closed Access | Times Cited: 267
Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review
Tatsuo Kanda, Taichiro Goto, Yosuke Hirotsu, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1358-1358
Open Access | Times Cited: 256
The Role of Nrf2 Activity in Cancer Development and Progression
Alina‐Andreea Zimța, Diana Cenariu, Alexandru Irimie, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1755-1755
Open Access | Times Cited: 228
Dysregulation of Nrf2 in Hepatocellular Carcinoma: Role in Cancer Progression and Chemoresistance
Azhwar Raghunath, Kiruthika Sundarraj, Frank Arfuso, et al.
Cancers (2018) Vol. 10, Iss. 12, pp. 481-481
Open Access | Times Cited: 166
The KEAP1–NRF2 System as a Molecular Target of Cancer Treatment
Keiko Taguchi, Masayuki Yamamoto
Cancers (2020) Vol. 13, Iss. 1, pp. 46-46
Open Access | Times Cited: 146
Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interaction
Rui Feng, Yuji Morine, Tetsuya Ikemoto, et al.
Cell Communication and Signaling (2018) Vol. 16, Iss. 1
Open Access | Times Cited: 154
Genetic alterations in hepatocellular carcinoma: An update
Zhao-Shan Niu, Xiao-Jun Niu, Wenhong Wang
World Journal of Gastroenterology (2016) Vol. 22, Iss. 41, pp. 9069-9069
Open Access | Times Cited: 153
Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib
Aline Houessinon, Catherine Franois, Chloé Sauzay, et al.
Molecular Cancer (2016) Vol. 15, Iss. 1
Open Access | Times Cited: 127
Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma
Derek Lee, Mingjing Xu, David Kung‐Chun Chiu, et al.
Journal of Clinical Investigation (2017) Vol. 127, Iss. 5, pp. 1856-1872
Open Access | Times Cited: 124
MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression
Zhikun Liu, Jie Li, Jun Chen, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 124
p62/SQSTM1—Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer
Koji Taniguchi, Shinichiro Yamachika, Feng He, et al.
FEBS Letters (2016) Vol. 590, Iss. 15, pp. 2375-2397
Open Access | Times Cited: 105
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis
Marta Anna Kowalik, Giulia Guzzo, Andrea Morandi, et al.
Oncotarget (2016) Vol. 7, Iss. 22, pp. 32375-32393
Open Access | Times Cited: 88
The interplay of oncogenic signaling, oxidative stress and ferroptosis in cancer
Wentao Zeng, Xiaohang Long, Pu‐Ste Liu, et al.
International Journal of Cancer (2023) Vol. 153, Iss. 5, pp. 918-931
Closed Access | Times Cited: 37
Nrf2 Mutagenic Activation Drives Hepatocarcinogenesis
Hoang Kieu Chi Ngo, Do‐Hee Kim, Young‐Nam Cha, et al.
Cancer Research (2017) Vol. 77, Iss. 18, pp. 4797-4808
Open Access | Times Cited: 75
Generation of a New Model Rat:Nrf2Knockout Rats Are Sensitive to Aflatoxin B1Toxicity
Keiko Taguchi, Misaki Takaku, Patricia A. Egner, et al.
Toxicological Sciences (2016) Vol. 152, Iss. 1, pp. 40-52
Open Access | Times Cited: 73
The NADPH oxidase NOX4 represses epithelial to amoeboid transition and efficient tumour dissemination
Eva Crosas‐Molist, Esther Bertrán, Irene Rodríguez‐Hernández, et al.
Oncogene (2016) Vol. 36, Iss. 21, pp. 3002-3014
Open Access | Times Cited: 68
Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies
Monica Mossenta, Davide Busato, Michele Dal Bo, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1668-1668
Open Access | Times Cited: 68
Patient‐derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management
Delphine Nicolle, Monique Fabrè, Marina Simon‐Coma, et al.
Hepatology (2016) Vol. 64, Iss. 4, pp. 1121-1135
Open Access | Times Cited: 61
NRF2 and the Ambiguous Consequences of Its Activation during Initiation and the Subsequent Stages of Tumourigenesis
Holly Robertson, Albena T. Dinkova‐Kostova, John D. Hayes
Cancers (2020) Vol. 12, Iss. 12, pp. 3609-3609
Open Access | Times Cited: 59
The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology
Juha M. T. Hyttinen, Ram Kannan, Szabolcs Felszeghy, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5800-5800
Open Access | Times Cited: 56
Nuclear factor erythroid 2–related factor 2 and β‐Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic Implications
Junyan Tao, Yekaterina Krutsenko, Akshata Moghe, et al.
Hepatology (2021) Vol. 74, Iss. 2, pp. 741-759
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top